ホーム > サポート > 参考文献

参考文献

Qiu S‑F, Chen Z, Zhu A‑R, et al. Successful clearance of persistent SARS‑CoV‑2 asymptomatic infection following a single dose of Ad5‑nCoV vaccine. Signal Transduct Target Ther. 2023;8:123. doi:10.1038/s41392-023-01345-3

Successful clearance of persistent SARS-CoV-2 asymptomatic infection following a single dose of Ad5-nCoV vaccine

製品推奨: Anti-SARS-CoV-2 Spike Protein (Trimer) Human IgG ELISA Kit 購入元: abinScience
Pan Y, Du J, Liu J, et al. Screening of potent neutralizing antibodies against SARS‑CoV‑2 using convalescent patients‑derived phage‑display libraries. Cell Discov. 2021;7:57. doi:10.1038/s41421-021-00295-w

Screening of potent neutralizing antibodies against SARS-CoV-2 using convalescent patients-derived phage-display libraries

製品推奨: SARS-CoV-2 Surrogate Virus Neutralization Test Kit 購入元: abinScience
Zhou Y, Lu X, Wang X, Ying T, Tan X. Potent Therapeutic Strategies for COVID-19 with Single-Domain Antibody Immunoliposomes Neutralizing SARS-CoV-2 and Lip/cGAMP Enhancing Protective Immunity. Int J Mol Sci. 2023;24(4):4068. Published 2023 Feb 17. doi:10.3390/ijms24044068

Potent Therapeutic Strategies for COVID-19 with Single-Domain Antibody Immunoliposomes Neutralizing SARS-CoV-2 and Lip/cGAMP Enhancing Protective Immunity

製品推奨: SARS-CoV-2 Surrogate Virus Neutralization Test Kit (Omicron) 購入元: abinScience
Tang H, Gao L, Wu Z, et al. Multiple SARS-CoV-2 Variants Exhibit Variable Target Cell Infectivity and Ability to Evade Antibody Neutralization. Front Immunol. 2022;13:836232. Published 2022 Mar 16. doi:10.3389/fimmu.2022.836232

Multiple SARS-CoV-2 Variants Exhibit Variable Target Cell Infectivity and Ability to Evade Antibody Neutralization

製品推奨: SARS-CoV-2 RBD (JN.1) ELISA Kit 購入元: abinScience
Qiu S‑F, Chen Z, Zhu A‑R, et al. Successful clearance of persistent SARS‑CoV‑2 asymptomatic infection following a single dose of Ad5‑nCoV vaccine. Signal Transduct Target Ther. 2023;8:123. doi:10.1038/s41392-023-01345-3

Successful clearance of persistent SARS-CoV-2 asymptomatic infection following a single dose of Ad5-nCoV vaccine

製品推奨: Anti-SARS-CoV-2 Spike Protein (Trimer) Human IgG ELISA Kit 購入元: abinScience
Pan Y, Du J, Liu J, et al. Screening of potent neutralizing antibodies against SARS‑CoV‑2 using convalescent patients‑derived phage‑display libraries. Cell Discov. 2021;7:57. doi:10.1038/s41421-021-00295-w

Screening of potent neutralizing antibodies against SARS-CoV-2 using convalescent patients-derived phage-display libraries

製品推奨: SARS-CoV-2 Surrogate Virus Neutralization Test Kit 購入元: abinScience
Zhou Y, Lu X, Wang X, Ying T, Tan X. Potent Therapeutic Strategies for COVID-19 with Single-Domain Antibody Immunoliposomes Neutralizing SARS-CoV-2 and Lip/cGAMP Enhancing Protective Immunity. Int J Mol Sci. 2023;24(4):4068. Published 2023 Feb 17. doi:10.3390/ijms24044068

Potent Therapeutic Strategies for COVID-19 with Single-Domain Antibody Immunoliposomes Neutralizing SARS-CoV-2 and Lip/cGAMP Enhancing Protective Immunity

製品推奨: SARS-CoV-2 Surrogate Virus Neutralization Test Kit (Omicron) 購入元: abinScience
Tang H, Gao L, Wu Z, et al. Multiple SARS-CoV-2 Variants Exhibit Variable Target Cell Infectivity and Ability to Evade Antibody Neutralization. Front Immunol. 2022;13:836232. Published 2022 Mar 16. doi:10.3389/fimmu.2022.836232

Multiple SARS-CoV-2 Variants Exhibit Variable Target Cell Infectivity and Ability to Evade Antibody Neutralization

製品推奨: SARS-CoV-2 RBD (JN.1) ELISA Kit 購入元: abinScience
Li B, Zhao Y, Wu X, et al. Abiotic Synthetic Antibody Inhibitor with Broad‑Spectrum Neutralization and Antiviral Efficacy against Escaping SARS‑CoV‑2 Variants. ACS Nano. 2023;17(7):?–?. doi:10.1021/acsnano.3c02050

Abiotic Synthetic Antibody Inhibitor with Broad-Spectrum Neutralization and Antiviral Efficacy against Escaping SARS-CoV-2 Variants

製品推奨: SARS-CoV-2 RBD (Omicron) ELISA Kit 購入元: abinScience

無料クォート取得